Ferenci, P. 2017. Hepatic encephalopathy. Gastroenterol Report (Oxf) 5 (2): 138–147.

Article  Google Scholar 

Amirshahrokhi, K., and A. Niapour. 2022. Carvedilol attenuates brain damage in mice with hepatic encephalopathy. International Immunopharmacology 111: 109119.

Article  CAS  PubMed  Google Scholar 

Bosoi, C.R., and C.F. Rose. 2013. Oxidative stress: A systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metabolic Brain Disease 28 (2): 175–178.

Article  CAS  PubMed  Google Scholar 

Jiang, W., H. Guo, D. Su, H. Xu, H. Gu, and K. Hao. 2019. Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin. International Immunopharmacology 75: 105774.

Article  CAS  PubMed  Google Scholar 

Althurwi, H.N., R.F. Abdel-Rahman, G.A. Soliman, H.A. Ogaly, F.K. Alkholifi, R.M. Abd-Elsalam, S.I. Alqasoumi, and M.S. Abdel-Kader. 2022. Protective effect of beta-carotene against myeloperoxidase-mediated oxidative stress and inflammation in rat ischemic brain injury. Antioxidants (Basel). 11 (12): 2344.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jayakumar, A.R., K.V. Rama Rao, and M.D. Norenberg. 2015. Neuroinflammation in hepatic encephalopathy: Mechanistic aspects. Journal of Clinical and Experimental Hepatology 5 (Suppl 1): S21–S28.

Article  PubMed  Google Scholar 

Ochoa-Sanchez, R., and C.F. Rose. 2018. Pathogenesis of hepatic encephalopathy in chronic liver disease. Journal of Clinical and Experimental Hepatology 8 (3): 262–271.

Article  PubMed  PubMed Central  Google Scholar 

Cheon, S.Y., M.Y. Kim, J. Kim, E.J. Kim, E.H. Kam, I. Cho, B.N. Koo, and S.Y. Kim. 2023. Hyperammonemia induces microglial NLRP3 inflammasome activation via mitochondrial oxidative stress in hepatic encephalopathy. Biomedical Journal 46 (5).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu, Y., Y. Yang, X. Chen, D. Jiang, F. Zhang, Y. Guo, B. Hu, G. Xu, S. Peng, L. Wu, and J. Hu. 2023. NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors. Translatinal Neurodegeneration 12 (1): 49.

Article  CAS  Google Scholar 

Contreras-García, I.J., N. Cárdenas-Rodríguez, A. Romo-Mancillas, C. Bandala, S.R. Zamudio, S. Gómez-Manzo, B. Hernández-Ochoa, J.G. Mendoza-Torreblanca, and L.A. Pichardo-Macías. 2022. Levetiracetam mechanisms of action: from molecules to systems. Pharmaceuticals (Basel) 15 (4): 475.

Article  PubMed  Google Scholar 

Kośmider, K., M. Kamieniak, S.J. Czuczwar, and B. Miziak. 2023. Second generation of antiepileptic drugs and oxidative stress. International Journal of Molecular Sciences 24 (4): 3873.

Article  PubMed  PubMed Central  Google Scholar 

Labh, R., R. Gupta, M. Narang, S. Halder, and R. Kar. 2021. Effect of valproate and add-on levetiracetam on inflammatory biomarkers in children with epilepsy. Epilepsy & Behavior 125: 108358.

Article  Google Scholar 

Matsuo, T., R. Komori, M. Nakatani, S. Ochi, A. Yokota-Nakatsuma, J. Matsumoto, F. Takata, S. Dohgu, Y. Ishihara, and K. Itoh. 2022. Levetiracetam suppresses the infiltration of neutrophils and monocytes and downregulates many inflammatory cytokines during epileptogenesis in pilocarpine-induced status epilepticus mice. International Journal of Molecular Sciences 23 (14): 7671.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong, J., H. Zhou, D. Lu, Z. Wang, H. Liu, Y. Sun, J. Xu, Y. Feng, and A. Xing. 2020. Levetiracetam Reduces Early Inflammatory Response After Experimental Intracerebral Hemorrhage by Regulating the Janus Kinase 2 (JAK2)-Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway. Medical Science Monitor 26: e922741.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng, X.Y., H.C. Zhang, Y.D. Lv, F.Y. Jin, X.J. Wu, J. Zhu, and Y. Ruan. 2022. Levetiracetam alleviates cognitive decline in Alzheimer’s disease animal model by ameliorating the dysfunction of the neuronal network. Frontiers in Aging Neuroscience 25 (14): 888784.

Article  Google Scholar 

Erbaş, O., F. Oltulu, M. Yılmaz, A. Yavaşoğlu, and D. Taşkıran. 2016. Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy. Diabetes Research and Clinical Practice 114: 106–116.

Article  PubMed  Google Scholar 

Kilicdag, H., K. Daglıoglu, S. Erdogan, A. Guzel, L. Sencar, S. Polat, and S. Zorludemir. 2013. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Human Development 89 (5): 355–360.

Article  CAS  PubMed  Google Scholar 

Mani, V., and Almutairi S. Rashed. 2023. Impact of levetiracetam on cognitive impairment, neuroinflammation, oxidative stress, and neuronal apoptosis caused by lipopolysaccharides in rats. Saudi Pharmaceutical Journal 31 (9): 101728.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amirshahrokhi, K., and M. Imani. 2023. Levetiracetam attenuates experimental ulcerative colitis through promoting Nrf2/HO-1 antioxidant and inhibiting NF-κB, proinflammatory cytokines and iNOS/NO pathways. International Immunopharmacology 119: 110165.

Article  CAS  PubMed  Google Scholar 

Amirshahrokhi, K. 2021. Acrylamide exposure aggravates the development of ulcerative colitis in mice through activation of NF-κB, inflammatory cytokines, iNOS, and oxidative stress. Iranian Journal of Basic Medical Sciences 24 (3): 312–321.

PubMed  PubMed Central  Google Scholar 

Levine, R.L., D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186: 464–478.

Article  CAS  PubMed  Google Scholar 

de Souza, A.G., A.J.M. Chaves Filho, J.V. Souza Oliveira, D.A.A. de Souza, I.S. Lopes, M.A.J. de Carvalho, K.A. de Lima, F.C. Florenço Sousa, S.M. Mendes Vasconcelos, D. Macedo, and M.M. de França Fonteles. 2019. Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties. Biomedicine & Pharmacotherapy 109: 429–439.

Article  Google Scholar 

Ignacio-Mejía, I., I.J. Contreras-García, J.G. Mendoza-Torreblanca, O.N. Medina-Campos, J. Pedraza-Chaverri, M.E. García-Cruz, A. Romo-Mancillas, S. Gómez-Manzo, C. Bandala, M.E. Sánchez-Mendoza, L.A. Pichardo-Macías, and N. Cárdenas-Rodríguez. 2023. Evaluation of the antioxidant activity of levetiracetam in a temporal lobe epilepsy model. Biomedicines. 11 (3): 848.

Article  PubMed  PubMed Central  Google Scholar 

Marini, H., C. Costa, M. Passaniti, M. Esposito, G.M. Campo, R. Ientile, E.B. Adamo, R. Marini, P. Calabresi, D. Altavilla, L. Minutoli, F. Pisani, and F. Squadrito. 2004. Levetiracetam protects against kainic acid-induced toxicity. Life Sciences 74 (10): 1253–1264.

Article  CAS  PubMed  Google Scholar 

Oliveira, A.A., J.P. Almeida, R.M. Freitas, V.S. Nascimento, L.M. Aguiar, H.V. Júnior, F.N. Fonseca, G.S. Viana, F.C. Sousa, and M.M. Fonteles. 2007. Effects of levetiracetam in lipid peroxidation level, nitrite-nitrate formation and antioxidant enzymatic activity in mice brain after pilocarpine-induced seizures. Cellular and Molecular Neurobiology 27 (3): 395–406.

Article  CAS  PubMed  Google Scholar 

Amirshahrokhi, K., and A. Abzirakan. 2022. Carvedilol attenuates acrylamide-induced brain damage through inhibition of oxidative, inflammatory, and apoptotic mediators. Iranian Journals of Basic Medical Sciences 25 (1): 60–67.

Google Scholar 

Häussinger, D., M. Butz, A. Schnitzler, and B. Görg. 2021. Pathomechanisms in hepatic encephalopathy. Biological Chemistry 402 (9): 1087–1110.

Article  PubMed  Google Scholar 

Suárez, I., G. Bodega, E. Arilla, V. Felipo, and B. Fernández. 2006. The expression of nNOS, iNOS and nitrotyrosine is increased in the rat cerebral cortex in experimental hepatic encephalopathy. Neuropathology and Applied Neurobiology 32 (6): 594–604.

Article  PubMed  Google Scholar 

Mohammad, H.M.F., M.M. Sami, S. Makary, E.A. Toraih, A.O. Mohamed, and S.H. El-Ghaiesh. 2019. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression. Life Sciences 232: 116588.

Article  CAS  PubMed  Google Scholar 

Zhang, Y.Y., L. Wang, H. Guo, T.T. Han, Y.H. Chang, and X.C. Cui. 2023. Levetiracetam attenuates diabetes-associated cognitive impairment and microglia polarization by suppressing neuroinflammation. Frontiers in Pharmacology 4: 1145819.

Article  Google Scholar 

Jayakumar, A.R., J.R. Bethea, X.Y. Tong, J. Gomez, and M.D. Norenberg. 2011. NF-κB in the mechanism of brain edema in acute liver failure: Studies in transgenic mice. Neurobiology of Diseases 41 (2): 498–507.

Article  CAS  Google Scholar 

Amirshahrokhi, K., and A. Niapour. 2022. Methylsulfonylmethane protects against ethanol-induced brain injury in mice through the inhibition of oxidative stress, proinflammatory mediators and apoptotic cell death.  International Immunopharmacology 106: 108638.

Article  CAS  PubMed  Google Scholar 

Zhang, L., J. Tan, X. Jiang, W. Qian, T. Yang, X. Sun, Z. Chen, and Q. Zhu. 2017. Neuron-derived CCL2 contributes to microglia activation and neurological decline in hepatic encephalopathy. Biological Research 50 (1): 26.

Article  PubMed  PubMed Central  Google Scholar 

Amirshahrokhi, K. 2021. Thalidomide reduces glycerol-induced acute kidney injury by inhibition of NF-κB, NLRP3 inflammasome, COX-2 and inflammatory cytokines. Cytokine 144: 155574.

Article  CAS  PubMed  Google Scholar 

França, M.E.R., R.K.L.G. Ramos, W.H. Oliveira, E. Duarte-Silva, S.M.R. Araújo, D.B. Lós, and C.A. Peixoto. 2019. Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy. Toxicology and Applied Pharmacology 379: 114673.

Article  PubMed  Google Scholar 

Jiao, F., Y. Wang, Q. Chen, P. Cao, C. Shi, M. Pei, L. Wang, and Z. Gong. 2021. Role of SIRT1 in hepatic encephalopathy: in vivo and in vitro studies focusing on the NLRP3 inflammasome. Oxidative Medicine and Cellular Longevity 2021: 5522708.

Article